NANO Nuclear Energy to Present and Participate in H.C. Wainwright & Co.’s 26th Annual Global Investment Conference in New York on September 9-11th, 2024
29 août 2024 09h30 HE
|
NANO Nuclear Energy Inc.
New York, N.Y., Aug. 29, 2024 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a vertically integrated advanced nuclear energy and technology company...
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
29 août 2024 08h00 HE
|
Phathom Pharmaceuticals
FLORHAM PARK, N.J., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
Pasithea Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
28 août 2024 09h11 HE
|
Pasithea
Pasithea Therapeutics will present at H.C. Wainwright’s Global Investment Conference, highlighting PAS-004 development for NF1 and cancer.
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
28 août 2024 07h00 HE
|
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
KSQ Therapeutics to Participate in Upcoming Investor Conferences
28 août 2024 07h00 HE
|
KSQ
KSQ Therapeutics to Participate in Upcoming Investor Conferences
Medigene to Present at Upcoming Investor Conferences
28 août 2024 05h00 HE
|
Medigene AG
Planegg/Martinsried, August 28, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor...
Optinose to Present at the H.C. Wainwright 26th Annual Global Investment Conference
26 août 2024 09h00 HE
|
Optinose, Inc.
YARDLEY, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced...
Arcutis to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
22 août 2024 08h00 HE
|
Arcutis Biotherapeutics, Inc.
Arcutis today announced that management will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference.
aTyr Pharma to Participate in September Investor Conferences
21 août 2024 08h00 HE
|
aTyr Pharma, Inc.
aTyr Pharma to Participate in September Investor Conferences
Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences
21 août 2024 08h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Myriad management will participate in two...